STEELE GLENN JR MD PHD
SEC insider (Form 3/4/5 filer). CIK 0001269131. Director at PTC THERAPEUTICS, INC. (PTCT). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in WARREN, NJ.
Companies STEELE GLENN JR MD PHD has filed insider reports for
- PTC THERAPEUTICS, INC. (PTCT): Director
STEELE GLENN JR MD PHD
CIK: 0001269131
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)2 (33.3%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTCT
PTC THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 30, 2026PTCT
PTC THERAPEUTICS, INC.
ExerciseDirect12K shares at avg. $11.23$135K - Sep 30, 2026PTCT
PTC THERAPEUTICS, INC.
SaleDirect12K shares at avg. $65.16$782K - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
ExerciseDirect12K shares at avg. $30.86$370K - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
SaleDirect12K shares at avg. $76.35$916K - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
AwardDirect4K shares- - Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
AwardDirect4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise | 12,000 | $11.23 | $134,760 | Direct |
| Sep 30, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale | 12,000 | $65.16 | $781,920 | Direct |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise | 12,000 | $30.86 | $370,320 | Direct |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale | 12,000 | $76.35 | $916,200 | Direct |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | Award | 4,000 | - | $0 | Direct |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | Award | 4,000 | - | $0 | Direct |
1-6 of 6 transactions